Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

Abstract:

:The use of recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) following autologous marrow transplantation for lymphoid malignancies was explored in a phase I/II dose escalation study. rhGM-CSF given as a 2-hour infusion daily for 14 days was well tolerated at doses up to 240 micrograms/m2/day. When compared with 86 disease-matched and treatment-matched historical controls, patients receiving greater than or equal to 60 micrograms/m2/day rhGM-CSF recovered neutrophil and platelet counts more rapidly, had fewer days with fever, and were discharged from the hospital sooner.

journal_name

Blood

journal_title

Blood

authors

Nemunaitis J,Singer JW,Buckner CD,Hill R,Storb R,Thomas ED,Appelbaum FR

subject

Has Abstract

pub_date

1988-08-01 00:00:00

pages

834-6

issue

2

eissn

0006-4971

issn

1528-0020

journal_volume

72

pub_type

杂志文章

相关文献

BLOOD文献大全
  • Marrow harvesting from normal donors.

    abstract::The experience at a single institution in harvesting marrow for allogeneic transplantation on 1,270 occasions from 1,160 normal donors is presented in detail, together with an analysis of all the donor complications. Four donors were less than 2 years old, and the youngest was 6 1/2 months. No special difficulties wer...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Buckner CD,Clift RA,Sanders JE,Stewart P,Bensinger WI,Doney KC,Sullivan KM,Witherspoon RP,Deeg HJ,Appelbaum FR

    更新日期:1984-09-01 00:00:00

  • An endogenous glycosylphosphatidylinositol-specific phospholipase D releases basic fibroblast growth factor-heparan sulfate proteoglycan complexes from human bone marrow cultures.

    abstract::Basic fibroblast growth factor (bFGF) is a hematopoietic cytokine that stimulates stromal and stem cell growth. It binds to a glycosylphosphatidylinositol (GPI)-anchored heparan sulfate proteoglycan on human bone marrow (BM) stromal cells. The bFGF-proteoglycan complex is biologically active and is released by additio...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Brunner G,Metz CN,Nguyen H,Gabrilove J,Patel SR,Davitz MA,Rifkin DB,Wilson EL

    更新日期:1994-04-15 00:00:00

  • Cyclosporin-A is selectively cytotoxic to human leukemic T cells in vitro.

    abstract::We have studied the antileukemic effects of cyclosporin-A (CyA) on the cells of a number of human hematopoietic biopsies and established cell lines in vitro. Cya killed the tumor cells but not the nonmalignant control cells from three of four patients with T-lymphocytic leukemia/lymphoma at concentrations comparable t...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Tötterman TH,Danersund A,Nilsson K,Killander A

    更新日期:1982-05-01 00:00:00

  • Effects of parenteral recombinant human macrophage colony-stimulating factor on monocyte number, phenotype, and antitumor cytotoxicity in nonhuman primates.

    abstract::Recombinant human macrophage colony-stimulating factor (rhM-CSF) was given to cynomolgus monkeys by continuous intravenous infusion or subcutaneous injection, at a dose of 50 to 100 micrograms/kg/d in repetitive 14-day cycles. Starting within 24 to 48 hours of initiation of rhM-CSF, there was a progressive increase in...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Munn DH,Garnick MB,Cheung NK

    更新日期:1990-05-15 00:00:00

  • Human neutrophils mediate trogocytosis rather than phagocytosis of CLL B cells opsonized with anti-CD20 antibodies.

    abstract::Polymorphonuclear neutrophils (PMNs) have previously been reported to mediate phagocytosis of anti-CD20-opsonized B cells from patients with chronic lymphocytic leukemia (CLL). However, recent data have suggested that PMNs, like macrophages, can also mediate trogocytosis. We have performed experiments to more precisel...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-08-735605

    authors: Valgardsdottir R,Cattaneo I,Klein C,Introna M,Figliuzzi M,Golay J

    更新日期:2017-05-11 00:00:00

  • Human platelet cGI-PDE: expression in yeast and localization of the catalytic domain by deletion mutagenesis.

    abstract::Cyclic adenosine monophosphate (cAMP) is an important modulator of platelet responses to agonists. Cyclic nucleotide phosphodiesterase (PDE) controls intracellular cAMP concentrations by hydrolyzing it to AMP. The major PDE activity in platelets is PDE3A (cyclic guanosine monophosphate [cGMP]-inhibited PDE). To obtain...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Cheung PP,Xu H,McLaughlin MM,Ghazaleh FA,Livi GP,Colman RW

    更新日期:1996-08-15 00:00:00

  • Unmaintained remissions in multiple myeloma.

    abstract::Twenty-eight patients with multiple myeloma responding to prior melphalan-prednisone combinations, but without additional chemotherapy, were followed until relapse. Patients receiving no further treatment had a median survival time similar to that of those receiving indefinite courses of melphalan-prednisone or carmus...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Alexanian R,Gehan E,Haut A,Saiki J,Weick J

    更新日期:1978-06-01 00:00:00

  • The role of the ADAMTS13 cysteine-rich domain in VWF binding and proteolysis.

    abstract::ADAMTS13 proteolytically regulates the platelet-tethering function of von Willebrand factor (VWF). ADAMTS13 function is dependent upon multiple exosites that specifically bind the unraveled VWF A2 domain and enable proteolysis. We carried out a comprehensive functional analysis of the ADAMTS13 cysteine-rich (Cys-rich)...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-08-594556

    authors: de Groot R,Lane DA,Crawley JT

    更新日期:2015-03-19 00:00:00

  • Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte.

    abstract::Peroxiredoxin 2 (Prx2), a thiol-dependent peroxidase, is the third most abundant protein in the erythrocyte, and its absence in knock-out mice gives rise to hemolytic anemia. We have found that in human erythrocytes, Prx2 was extremely sensitive to oxidation by H(2)O(2), as dimerization was observed after exposure of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-048728

    authors: Low FM,Hampton MB,Peskin AV,Winterbourn CC

    更新日期:2007-03-15 00:00:00

  • In vivo hematologic effects of recombinant interleukin-6 on hematopoiesis and circulating numbers of RBCs and WBCs.

    abstract::Interleukin-6 (IL-6) administered as a single intravenous (IV) injection caused the following changes in the peripheral circulation of rats: (a) a biphasic neutrophilia with an initial peak at 1.5 hours and a second sustained wave of neutrophilia between four and 12 hours, (b) a mild lymphocytosis at 0.5 hours and a m...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ulich TR,del Castillo J,Guo KZ

    更新日期:1989-01-01 00:00:00

  • Experience with protein A-immunoadsorption in treatment-resistant adult immune thrombocytopenic purpura.

    abstract::Extracorporeal immunoadsorption of plasma to remove IgG and circulating immune complexes (CIC) was evaluated as a therapy for adults with treatment-resistant immune thrombocytopenic purpura (ITP). Seventy-two patients with initial platelet counts less than 50,000/microL who had failed at least two other therapies were...

    journal_title:Blood

    pub_type: 临床试验,杂志文章,多中心研究

    doi:

    authors: Snyder HW Jr,Cochran SK,Balint JP Jr,Bertram JH,Mittelman A,Guthrie TH Jr,Jones FR

    更新日期:1992-05-01 00:00:00

  • p53 abnormalities in splenic lymphoma with villous lymphocytes.

    abstract::The incidence and role of p53 abnormalities have not been reported in splenic lymphoma with villous lymphocytes (SLVL), the leukemic counterpart of splenic marginal zone lymphoma. Because p53 abnormalities correlate with progressive and refractory disease in cancer and isochromosome 17q has been described in SLVL, a l...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.v97.11.3552

    authors: Gruszka-Westwood AM,Hamoudi RA,Matutes E,Tuset E,Catovsky D

    更新日期:2001-06-01 00:00:00

  • Cell interactions influencing murine marrow megakaryocytes: nature of the potentiator cell in bone marrow.

    abstract::Auxiliary bone marrow cells are required for optimal murine megakaryocyte colony formation in addition to progenitor cells and a colony stimulating activity (CSA) present in WEHI-3 cell conditioned medium. These auxiliary cells are adherent, with a sedimentation rate of 5.8 mm hr-1 and buoyant density of 1.065-1.078 g...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Williams N,Jackson H,Ralph P,Nakoinz I

    更新日期:1981-01-01 00:00:00

  • Growth inhibition of a human myeloma cell line by all-trans retinoic acid is not mediated through downregulation of interleukin-6 receptors but through upregulation of p21(WAF1).

    abstract::All-trans retinoic acid (ATRA) has previously been shown to inhibit the growth of OPM-2 human myeloma cells. The growth inhibition was postulated to result from a transcriptional downregulation of interleukin-6 receptor alpha (IL-6Ralpha) with IL-6Rbeta (gp130) unaffected. To formally test this hypothesis, an expressi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chen YH,Lavelle D,DeSimone J,Uddin S,Platanias LC,Hankewych M

    更新日期:1999-07-01 00:00:00

  • Failure of W/Wv mouse-derived cultured mast cells to enter S phase upon contact with NIH/3T3 fibroblasts.

    abstract::Although W/Wv mutant mice are profoundly deficient in tissue mast cells, these mice do have cells with similar features of mast cells that develop from their bone marrow cells as efficiently as those from congenic +/+ mice in pokeweed mitogen-stimulated spleen cell-conditioned medium (PWM-SCM). With cultured mast cell...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Fujita J,Nakayama H,Onoue H,Ebi Y,Kanakura Y,Kuriu A,Kitamura Y

    更新日期:1988-08-01 00:00:00

  • Interstitial insertion of retinoic acid receptor-alpha gene in acute promyelocytic leukemia with normal chromosomes 15 and 17.

    abstract::The translocation t(15;17)(q22;q21) is seen exclusively in patients with acute promyelocytic leukemia (APL) and in the promyelocytic blast crisis of chronic myeloid leukemia (CML). This translocation juxta-poses the promyelocytic leukemia (PML) gene on chromosome 15 and the retinoic acid receptor-alpha (RARA) gene on ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hiorns LR,Min T,Swansbury GJ,Zelent A,Dyer MJ,Catovsky D

    更新日期:1994-05-15 00:00:00

  • Architectural and functional heterogeneity of hematopoietic stem/progenitor cells in non-del(5q) myelodysplastic syndromes.

    abstract::Myelodysplastic syndromes (MDSs) are hematopoietic stem cell disorders in which recurrent mutations define clonal hematopoiesis. The origin of the phenotypic diversity of non-del(5q) MDS remains unclear. Here, we investigated the clonal architecture of the CD34+CD38- hematopoietic stem/progenitor cell (HSPC) compartme...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-03-707745

    authors: Chesnais V,Arcangeli ML,Delette C,Rousseau A,Guermouche H,Lefevre C,Bondu S,Diop M,Cheok M,Chapuis N,Legros L,Raynaud S,Willems L,Bouscary D,Lauret E,Bernard OA,Kosmider O,Pflumio F,Fontenay M

    更新日期:2017-01-26 00:00:00

  • Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity.

    abstract::To evaluate the importance of the thymus for the reconstitution of immunity in recipients of a T-cell-depleted bone marrow, we measured the appearance of CD4(+)CD45RA(+)RO(-) naive T cells (thymic rebound), restoration of the diversity of the T-cell-receptor (TCR) repertoire and the response to vaccinations with tetan...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Roux E,Dumont-Girard F,Starobinski M,Siegrist CA,Helg C,Chapuis B,Roosnek E

    更新日期:2000-09-15 00:00:00

  • Effect of splenectomy on tolerance to combination chemotherapy in patients with lymphoma.

    abstract::Enhanced tolerance to combination chemotherapy has been cited as an ancillary benefit of staging laparotomy and splenectomy in Hodgkin's disease. Seventeen patients with Hodgkin's disease and 15 with non-Hodgkin's lymphoma were subjected to nontherapeutic splenectomy as part of the staging procedure prior to their ini...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Ihde DC,DeVita VT,Canellos GP,Young RC

    更新日期:1976-02-01 00:00:00

  • Factor IXAlabama: a point mutation in a clotting protein results in hemophilia B.

    abstract::Factor IXAlabama is a variant factor IX molecule responsible for a clinically moderate form of hemophilia B. Twenty-five kilobases (kb) of the variant gene, including seven exons coding for the structural protein, were cloned and characterized. The restriction map and the arrangement of coding regions are identical to...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Davis LM,McGraw RA,Ware JL,Roberts HR,Stafford DW

    更新日期:1987-01-01 00:00:00

  • The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia.

    abstract::To identify new cytogenetic abnormalities associated with leukemogenesis or disease outcome, T-cell acute lymphoblastic leukemia (T-ALL) patient samples were analyzed by means of the array-comparative genome hybridization technique (array-CGH). Here, we report the identification of a new recurrent and cryptic deletion...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-04-019927

    authors: Van Vlierberghe P,van Grotel M,Beverloo HB,Lee C,Helgason T,Buijs-Gladdines J,Passier M,van Wering ER,Veerman AJ,Kamps WA,Meijerink JP,Pieters R

    更新日期:2006-11-15 00:00:00

  • Heterogeneity in Fanconi anemia: evidence for 2 new genetic subtypes.

    abstract::Fanconi anemia (FA) is an autosomal recessive syndrome featuring diverse symptoms including progressive bone marrow failure and early occurrence of acute myeloid leukemia. Nine genetic subtypes have been described for FA (A, B, C, D1, D2, E, F, G, and L), all of which have been connected to distinct disease genes, exc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2003-08-2915

    authors: Levitus M,Rooimans MA,Steltenpool J,Cool NF,Oostra AB,Mathew CG,Hoatlin ME,Waisfisz Q,Arwert F,de Winter JP,Joenje H

    更新日期:2004-04-01 00:00:00

  • CD33 expression and P-glycoprotein-mediated drug efflux inversely correlate and predict clinical outcome in patients with acute myeloid leukemia treated with gemtuzumab ozogamicin monotherapy.

    abstract::Gemtuzumab ozogamicin (GO) contains an anti-CD33 antibody to facilitate uptake of a toxic calicheamicin-gamma(1) derivative. While recent in vitro data demonstrated a quantitative relationship between CD33 expression and GO cytotoxicity, previous correlative studies failed to identify a significant association between...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2006-09-047399

    authors: Walter RB,Gooley TA,van der Velden VH,Loken MR,van Dongen JJ,Flowers DA,Bernstein ID,Appelbaum FR

    更新日期:2007-05-15 00:00:00

  • The gene for the alpha 4 subunit of the VLA-4 integrin maps to chromosome 2Q31-32.

    abstract::The VLA-4 integrin (CD49d/CD29), initially discovered on lymphoid cells, is actually known to be highly expressed on T cells, B cells, monocytes, and derived cell lines. Unlike other VLA integrins, mainly involved in cell-matrix adhesive interactions, VLA-4 has also been implicated in several cellular interactions. Ba...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Zhang ZH,Vekemans S,Aly MS,Jaspers M,Marynen P,Cassiman JJ

    更新日期:1991-11-01 00:00:00

  • Leukocyte integrin CD11b promoter directs expression in lymphocytes and granulocytes in transgenic mice.

    abstract::The human leukocyte integrin subunit CD11b is expressed predominantly on myelomonocytic cells. To identify CD11b promoter sequences important for myelomonocytic gene expression and to assess the utility of the CD11b promoter for expressing heterologous genes in vivo, we generated transgenic mice with a human CD4 repor...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Back A,East K,Hickstein D

    更新日期:1995-02-15 00:00:00

  • Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia.

    abstract::Val34Leu polymorphism of the A subunit of coagulation factor XIII (FXIII-A) is located in the activation peptide (AP) just 3 amino acids away from the thrombin cleavage site. This mutation has been associated with a protective effect against occlusive arterial diseases and venous thrombosis; however, its biochemical c...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Balogh I,Szôke G,Kárpáti L,Wartiovaara U,Katona E,Komáromi I,Haramura G,Pfliegler G,Mikkola H,Muszbek L

    更新日期:2000-10-01 00:00:00

  • Clonal regulatory T cells specific for a red blood cell autoantigen in human autoimmune hemolytic anemia.

    abstract::Regulatory T (Tr) cells have the potential to treat immune-mediated disease, but cloning such cells for study from patients with autoimmune disease has proven difficult. Here, we describe autoantigen-specific, interleukin-10 (IL-10)-secreting Tr cell clones recovered ex vivo from a patient with autoimmune hemolytic an...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2007-07-101345

    authors: Ward FJ,Hall AM,Cairns LS,Leggat AS,Urbaniak SJ,Vickers MA,Barker RN

    更新日期:2008-01-15 00:00:00

  • L-selectin shedding affects bacterial clearance in the lung: a new regulatory pathway for integrin outside-in signaling.

    abstract::Pneumonia induced by Gram-negative bacteria is a common and serious disease associated with high morbidity and mortality. Elimination of bacterial pathogens relies on the recruitment and functions of neutrophils. The adhesion molecule L-selectin has recently been implicated in integrin activation in neutrophils (insid...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood.2019000685

    authors: Cappenberg A,Margraf A,Thomas K,Bardel B,McCreedy DA,Van Marck V,Mellmann A,Lowell CA,Zarbock A

    更新日期:2019-10-24 00:00:00

  • Ssb1 and Ssb2 cooperate to regulate mouse hematopoietic stem and progenitor cells by resolving replicative stress.

    abstract::Hematopoietic stem and progenitor cells (HSPCs) are vulnerable to endogenous damage and defects in DNA repair can limit their function. The 2 single-stranded DNA (ssDNA) binding proteins SSB1 and SSB2 are crucial regulators of the DNA damage response; however, their overlapping roles during normal physiology are incom...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2016-06-725093

    authors: Shi W,Vu T,Boucher D,Biernacka A,Nde J,Pandita RK,Straube J,Boyle GM,Al-Ejeh F,Nag P,Jeffery J,Harris JL,Bain AL,Grzelak M,Skrzypczak M,Mitra A,Dojer N,Crosetto N,Cloonan N,Becherel OJ,Finnie J,Skaar JR,Walkle

    更新日期:2017-05-04 00:00:00

  • New MLLT10 gene recombinations in pediatric T-acute lymphoblastic leukemia.

    abstract::The MLLT10 gene, located at 10p13, is a known partner of MLL and PICALM in specific leukemic fusions generated from recurrent 11q23 and 11q14 chromosome translocations. Deep sequencing recently identified NAP1L1/12q21 as another MLLT10 partner in T-cell acute lymphoblastic leukemia (T-ALL). In pediatric T-ALL, we have...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-02-487256

    authors: Brandimarte L,Pierini V,Di Giacomo D,Borga C,Nozza F,Gorello P,Giordan M,Cazzaniga G,Te Kronnie G,La Starza R,Mecucci C

    更新日期:2013-06-20 00:00:00